Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price-Reference-Cited by-同舟云学术

Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price

Published:2022-01 Issue:1 Volume:8 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Sinha Pranay¹²^ORCID,Barocas Joshua A.³^ORCID

Affiliation:

1. Section of Infectious Diseases Boston Medical Center (BMC) Boston Massachusetts USA

2. Department of Medicine Boston University School of Medicine (BUSM) Boston Massachusetts USA

3. Divisions of General Internal Medicine and Infectious Diseases University of Colorado Anschutz Medical Campus Aurora Colorado USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12256

Reference13 articles.

1. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years

2. Monetary Costs of Dementia in the United States

3. Federal Drug Administration.FDA grants accelerated approval for Alzheimer's drug. 2021. Accessed July 9 2021https://www.fda.gov/news‐events/press‐announcements/fda‐grants‐accelerated‐approval‐alzheimers‐drug

4. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

5. Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease;Neurology;2024-04-09

2. Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease;Ageing Research Reviews;2024-03

3. Effect of Dietary Habits on Alzheimer’s Disease Progression;Yonsei Medical Journal;2024

4. The cost and benefit of targeting amyloid plaques to treat alzheimer’s disease;Annals of Alzheimer's and Dementia Care;2023-12-30

5. Aducanumab: an uprising hope with vague horizons;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2023-06-29